From an operator's frustration
to a publicly traded technology platform.

Built by operators, for operators.

Cyphaira's first product, SolvixLMS, was not built in a research lab. It was built on a production floor, by people who were tired of running their facility on a "Frankenstack" of spreadsheets, disconnected inventory tools, and compliance trackers that were never designed to talk to each other.

The team behind SolvixLMS — including the company's solventless extraction operators — spent years processing cannabis biomass at one of the largest solventless facilities in the U.S. They lived the gap between what state regulators required, what federal recordkeeping was about to require, and what the tools on the market actually delivered. So they built the platform they needed.

In April 2026, the DEA rescheduled state-licensed medical cannabis from Schedule I to Schedule III. Federal recordkeeping under Schedule III requires batch-level production data that legacy inventory trackers were never built to capture. SolvixLMS, by accident of when and why it was designed, was already built for exactly that. The regulatory window closed the gap between what the operators needed and what the broader industry suddenly needed too.

The Company's anchor operator continues to run SolvixLMS in alpha and has processed 50,000+ lbs of biomass. SolvixLMS is expected to begin onboarding paying customers on or about June 15, 2026.